X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/07/10/2701644/0/en/Clearside-Biomedical-Asia-Pacific-Partner-Arctic-Vision-Announces-the-Acceptance-in-Australia-of-its-New-Drug-Application-for-Suprachoroidal-Use-of-Arcatus-for-the-Treatment-of-Uve.html
https://www.asiaone.com/business/arctic-vision-announces-first-patient-enrolled-phase-iii-clinical-trial-arvn003-presbyopia
https://www.prnewswire.com/news-releases/arctic-vision-announces-first-patient-dosed-in-phase-iii-study-of-arvn001-for-treatment-of-macular-edema-associated-with-uveitis-ume-301429973.html
https://www.prnewswire.com/news-releases/arctic-vision-announces-addition-of-novel-mydriatic-drug-mydcombi-arvn004-to-eyenovia-commercialization-deal-301378890.html
https://www.globenewswire.com/news-release/2021/09/09/2294162/0/en/Clearside-Biomedical-Expands-XIPERE-License-Agreement-with-Arctic-Vision-to-Include-Australia-New-Zealand-India-and-ASEAN-Countries.html
https://www.prnewswire.com/news-releases/innovent-announces-sintilimab-in-combination-with-chemotherapy-meets-the-primary-endpoint-of-overall-survival-in-the-phase-3-orient-16-study-for-the-first-line-treatment-of-advanced-or-metastatic-gastric-or-gastroesophageal-juncti-301355470.html
https://eyewire.news/articles/arctic-vision-announces-exclusive-licensing-agreement-with-actualeyes/#:~:text=Arctic%20Vision%20and%20ActualEyes%2C%20a,%2C%20AE%2D101%2C%20for%20the
Market Place
Share 
